The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-κB activation in anaplastic large cell lymphoma
Open Access
- 30 April 2004
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 5 (4) , 353-364
- https://doi.org/10.1016/s1535-6108(04)00084-4
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- AP-1 Mediated Relief of Repressive Activity of the CD30 Promoter Microsatellite in Hodgkin and Reed-Sternberg CellsThe American Journal of Pathology, 2003
- Cytoplasmic Aggregation of TRAF2 and TRAF5 Proteins in the Hodgkin-Reed-Sternberg CellsThe American Journal of Pathology, 2002
- Tyrosine Kinase c-Src Constitutes a Bridge between Cystic Fibrosis Transmembrane Regulator Channel Failure and MUC1 Overexpression in Cystic FibrosisJournal of Biological Chemistry, 2002
- Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in Hodgkin–Reed-Sternberg cellsOncogene, 2002
- Pleiotropic Signal Transduction Mediated by Human CD30: A Member of the Tumor Necrosis Factor Receptor (TNFR) FamilyLeukemia & Lymphoma, 2002
- Regulation ofMUC1Expression in Human Mammary Cell Lines by the c-ErbB2 and Ras Signaling PathwaysDNA and Cell Biology, 2001
- Mapping the Functional Domains of Nucleolar Protein B23Journal of Biological Chemistry, 2000
- CD30 in Normal and Neoplastic CellsClinical Immunology, 1999
- Nucleolar protein B23 has molecular chaperone activitiesProtein Science, 1999
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994